Table 4.
B | S.E | Wals | P-value | OR | 95% CI | |||
---|---|---|---|---|---|---|---|---|
Model 1 | Q1 | 76.60 | < 0.001 | 1.00 | ||||
Q2 | 1.27 | 0.31 | 16.94 | < 0.001 | 3.55 | 1.94 | 6.48 | |
Q3 | 1.76 | 0.29 | 35.68 | < 0.001 | 5.82 | 3.27 | 10.37 | |
Q4 | 2.24 | 0.29 | 60.59 | < 0.001 | 9.35 | 5.33 | 16.42 | |
Model 2 | Q1 | 57.55 | < 0.001 | |||||
Q2 | 1.17 | 0.31 | 14.22 | < 0.001 | 3.21 | 1.75 | 5.89 | |
Q3 | 1.62 | 0.30 | 29.93 | < 0.001 | 5.07 | 2.84 | 9.08 | |
Q4 | 2.00 | 0.29 | 47.26 | < 0.001 | 7.36 | 4.17 | 13.00 | |
Model 3 | Q1 | 50.36 | < 0.001 | |||||
Q2 | 1.13 | 0.31 | 13.23 | < 0.001 | 3.10 | 1.68 | 5.69 | |
Q3 | 1.59 | 0.30 | 28.01 | < 0.001 | 4.89 | 2.72 | 8.80 | |
Q4 | 1.94 | 0.30 | 42.49 | < 0.001 | 6.97 | 3.89 | 12.50 |
Model 1: Not adjusted
Model 2: Adjusted for sex, age, smoking, drinking, and physical activity
Model 3: Adjusted for sex, age, smoking, drinking, physical activity, Cr, diabetes, hyperlipidemia, and hypertension
Cr creatinine